Literature DB >> 19809297

Postoperative complications after transthoracic esophagectomy for cancer of the esophagus and gastroesophageal junction are correlated with early cancer recurrence: role of systematic grading of complications using the modified Clavien classification.

Toni Lerut1, Johnny Moons, Willy Coosemans, Dirk Van Raemdonck, Paul De Leyn, Herbert Decaluwé, Georges Decker, Philippe Nafteux.   

Abstract

OBJECTIVES: To assess the impact of postoperative complications after transthoracic esophagectomy, using the modified Clavien classification, on recurrence and on its timing in patients with cancer of the esophagus or gastroesophageal junction. BACKGROUND DATA: It is hypothesized that complications after esophagectomy for cancer may have a negative effect on recurrence and its timing because of negative interference with the immune system.
METHODS: Out of 150 consecutive patients operated with curative intent between January 2005 and May 2006, the data of 138 patients with macroscopically complete resection and no synchronous other malignancy were graded according to the modified Clavien classification. Uni- and multivariable analyses were performed to study the impact of postoperative complications on tumor recurrence and its timing.
RESULTS: Mean age was 63.1 years, male-female ratio was 4:1; 76.1% of the patients underwent primary surgery, 23.9% received induction therapy, R0-resection rate was 92.8%. Adenocarcinoma was found in 75%. Complication rates according to the modified Clavien classification were grade 0: 29.7%, grade 2: 35.5%, grade 3: 17.4%, grade 4: 15.9%, and grade 5 (postoperative mortality): 1.4%. Ten patients developed recurrence within 6 months, 29 within 12 months, 39 within 18 months, 42 within 24 months, totaling up to 47 at 3 years. Univariable analysis retained complications, LN-status, number of positive nodes, extracapsular lymph node involvement (EC LNI), pStage, pT, and R1-status as factors significantly influencing occurrence of recurrence. In the multivariable model, presence of complications, EC LNI, and R1-status were independent negative factors. Cox-regression analysis also identified these same 3 factors as significant determinators for the timing of recurrence.
CONCLUSIONS: This study indicates a correlation between complications and early recurrence and its timing. Modified Clavien classification, beside R1-status and EC LNI, appears to be a useful prognostic indicator of early recurrence and its timing. Achieving esophagectomy without postoperative complications is of utmost importance also for oncologic reasons given its negative potential on early oncologic outcome.

Entities:  

Mesh:

Year:  2009        PMID: 19809297     DOI: 10.1097/SLA.0b013e3181bdd5a8

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  75 in total

1.  Mediastinoscopy-assisted esophagectomy for esophageal cancer in patients with serious comorbidities.

Authors:  Naohiko Koide; Daisuke Takeuchi; Akira Suzuki; Shinichi Miyagawa
Journal:  Surg Today       Date:  2011-11-10       Impact factor: 2.549

2.  Evaluation of postoperative pancreatic fistula after total gastrectomy with D2 lymphadenectomy by ISGPF classification.

Authors:  Yuichiro Miki; Masanori Tokunaga; Etsuro Bando; Yutaka Tanizawa; Taiichi Kawamura; Masanori Terashima
Journal:  J Gastrointest Surg       Date:  2011-08-11       Impact factor: 3.452

3.  Prolonged postoperative length of stay is associated with poor overall survival after an esophagectomy for esophageal cancer.

Authors:  Longfei Ma; Jingpei Li; Longlong Shao; Dong Lin; Jiaqing Xiang
Journal:  J Thorac Dis       Date:  2015-11       Impact factor: 2.895

4.  Response to preoperative chemotherapy predicts survival in patients undergoing hepatectomy for liver metastases from gastric and esophageal cancer.

Authors:  Andreas Andreou; Luca Viganò; Giuseppe Zimmitti; Daniel Seehofer; Martin Dreyer; Andreas Pascher; Marcus Bahra; Wenzel Schoening; Volker Schmitz; Peter C Thuss-Patience; Timm Denecke; Gero Puhl; Jean-Nicolas Vauthey; Peter Neuhaus; Lorenzo Capussotti; Johann Pratschke; Sven-Christian Schmidt
Journal:  J Gastrointest Surg       Date:  2014-08-27       Impact factor: 3.452

5.  Risk factors associated with early recurrence of adenocarcinoma of gastroesophageal junction after curative resection.

Authors:  Guodong Wang; Aiwen Wu; Xiaojing Cheng; Jiafu Ji
Journal:  Chin J Cancer Res       Date:  2013-06       Impact factor: 5.087

6.  Cancer Recurrence After Esophagectomy: Impact of Postoperative Infection in Propensity-Matched Cohorts.

Authors:  Vernissia Tam; James D Luketich; Daniel G Winger; Inderpal S Sarkaria; Ryan M Levy; Neil A Christie; Omar Awais; Manisha R Shende; Katie S Nason
Journal:  Ann Thorac Surg       Date:  2016-06-25       Impact factor: 4.330

7.  Surgical quality: more than just margins and lymph nodes.

Authors:  Aaron R Sasson; Quan P Ly; Chandrakanth Are
Journal:  Gastrointest Cancer Res       Date:  2009-09

8.  Prophylactic effect of neoadjuvant chemotherapy in gastric cancer patients with postoperative complications.

Authors:  Kojiro Eto; Naoki Hiki; Koshi Kumagai; Yoshiaki Shoji; Yasuo Tsuda; Yosuke Kano; Itaru Yasufuku; Yasuhiro Okumura; Masahiro Tsujiura; Satoshi Ida; Souya Nunobe; Manabu Ohashi; Takeshi Sano; Toshiharu Yamaguchi
Journal:  Gastric Cancer       Date:  2017-11-29       Impact factor: 7.370

9.  The impact of postoperative complications on the administration of adjuvant therapy following pancreaticoduodenectomy for adenocarcinoma.

Authors:  Wenchuan Wu; Jin He; John L Cameron; Martin Makary; Kevin Soares; Nita Ahuja; Neda Rezaee; Joseph Herman; Lei Zheng; Daniel Laheru; Michael A Choti; Ralph H Hruban; Timothy M Pawlik; Christopher L Wolfgang; Matthew J Weiss
Journal:  Ann Surg Oncol       Date:  2014-04-26       Impact factor: 5.344

10.  Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Resectable Gastroesophageal Junction and Gastric Adenocarcinoma.

Authors:  Sam C Wang; Joanne F Chou; Vivian E Strong; Murray F Brennan; Marinela Capanu; Daniel G Coit
Journal:  Ann Surg       Date:  2016-02       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.